RRA
COLL icon

Round Rock Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Round Rock Advisors’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$387K Hold
10,690
– – 0.05% 245
2026
Q1 		$354K Hold
10,690
– – 0.05% 237
2025
Q4 		$495K Buy
10,690
+4,008
+60% +$168K 0.07% 195
2025
Q3 		$237K Buy
+6,682
New +$232K 0.04% 285

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Round Rock Advisors's COLL Position: Q2 2026 in Review

Round Rock Advisors held its Collegium Pharmaceutical (COLL) position steady in Q2 2026 at 10,690 shares worth $387K. The position accounts for 0.05% of the portfolio, ranked #245.

Round Rock Advisors first reported a position in COLL in Q3 2025 and has held it in 4 quarters since. The position peaked at $495K in Q4 2025. 280 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Round Rock Advisors held 10,690 shares of Collegium Pharmaceutical worth $387K as of Q2 2026.
  • Round Rock Advisors left its Collegium Pharmaceutical share count unchanged in Q2 2026.
  • Collegium Pharmaceutical made up 0.05% of Round Rock Advisors's portfolio in Q2 2026, its #245 holding.
  • Round Rock Advisors first reported a position in Collegium Pharmaceutical in Q3 2025 and has held it in 4 quarters since.
  • Round Rock Advisors's Collegium Pharmaceutical position peaked at $495K in Q4 2025.
  • 280 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Round Rock Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.